Can Acupuncture Help Trigeminal Neuralgia?

Acupuncture shows promise as a treatment for trigeminal neuralgia, with several meta-analyses reporting pain reductions that match or exceed those of the standard first-line drug, carbamazepine. The catch is that nearly all the supporting trials are rated low quality, and only one rigorous sham-controlled randomized trial has been published to date. That single trial did find real pain relief beyond placebo, which is encouraging, but the broader evidence base needs stronger studies before firm conclusions are possible.

Why People With Trigeminal Neuralgia Look for Alternatives

Trigeminal neuralgia produces sudden, severe jolts of facial pain, often triggered by everyday activities like chewing, talking, or a light breeze across the cheek. The pain follows the path of the trigeminal nerve, and in many cases the underlying cause is a blood vessel pressing against the nerve where it exits the brainstem.¹ Attacks can be so intense that the condition has been called “the suicide disease” in patient communities.

Carbamazepine, an anticonvulsant, has been the go-to medication for decades. It works, but side effects drive a significant number of people to quit or cut their dose. In a real-world study of 354 patients, roughly 30 percent of those on carbamazepine had side effects serious enough to stop or reduce the drug, and overall side effects hit about 44 percent of carbamazepine users.² Drowsiness, dizziness, nausea, and cognitive fog are common complaints. Oxcarbazepine, a related drug, fares somewhat better on side effects but still causes problems for about a third of users.

Surgery is the other major option, particularly microvascular decompression, which physically moves the offending blood vessel off the nerve. Long-term data show that about 70 percent of patients remain pain-free without medication ten years after the procedure, but 30 percent experience a return of pain, and roughly 11 percent go back for a second surgery.³ Brain surgery also carries inherent risks, including hearing loss and facial numbness, that not everyone is willing to accept. Given the side-effect burden of drugs and the invasiveness of surgery, it makes sense that patients look into acupuncture and other non-pharmacological options.

What the Clinical Evidence Actually Shows

Multiple systematic reviews and meta-analyses have pooled trial data on acupuncture for trigeminal neuralgia, and they tend to reach similar conclusions: acupuncture appears to reduce pain and improve response rates compared to carbamazepine alone. A 2023 meta-analysis combining 29 randomized controlled trials found that acupuncture improved response rates by about 20 percent relative to carbamazepine and produced lower pain scores, though the certainty of the evidence was rated low.⁴ A separate meta-analysis with sequential analysis came to a similar conclusion, finding statistically better pain relief with acupuncture than carbamazepine.⁵

The strongest individual piece of evidence comes from a randomized, sham-controlled factorial trial published in the Journal of Neurology in 2024. This study used a rigorous design with four groups: real electroacupuncture plus carbamazepine, sham electroacupuncture plus carbamazepine, real electroacupuncture plus placebo pill, and sham electroacupuncture plus placebo pill. Real electroacupuncture beat sham at every time point measured, out to 28 weeks. The combination of real electroacupuncture and carbamazepine together produced the largest pain reductions of any group.⁶ One noteworthy detail: carbamazepine’s effect appeared to fade over time, with diminishing pain reduction at the 16- and 28-week marks, while electroacupuncture maintained a meaningful reduction through the full follow-up period.

This matters because the vast majority of earlier trials compared acupuncture to carbamazepine without blinding, meaning patients knew exactly what treatment they were getting. That kind of design cannot separate the real therapeutic effect of needle stimulation from the powerful placebo response that comes with any hands-on treatment. The factorial trial, by including sham electroacupuncture with non-penetrating needles and placebo pills, specifically addressed that weakness.⁷

The Problem With Evidence Quality

An earlier systematic review from 2011, looking at the state of the field before most of the recent trials existed, found that all 12 included studies were too low in quality to pool statistically. Only four of those trials concluded that acupuncture was superior to carbamazepine; the other eight found no significant difference.⁸ Things have improved since then, with more and larger trials, but the recurring issue is that most studies still lack sham controls, proper blinding, or adequate follow-up periods.

The 2023 meta-analysis that found favorable results for acupuncture rated its own confidence in those results as “low” across most outcomes and “very low” for the adverse-event comparison.⁴ “Low certainty” in evidence-grading language means future high-quality studies could substantially change the estimated effect. The direction of the signal is encouraging, in other words, but the size of the benefit could shrink, grow, or disappear when better trials are done.

Why is trigeminal neuralgia research in acupuncture so hard to do well? Partly because the condition is uncommon enough that recruiting large numbers of patients takes time. Partly because blinding is inherently tricky with needle-based treatments: even sham acupuncture involves touching the patient’s skin, and experienced acupuncture patients may notice the difference. And partly because most of the published trials originate from a single country’s research tradition, raising concerns about publication bias and generalizability. The 2024 factorial trial is a step in the right direction, but one well-designed study does not settle a question.

How Acupuncture Might Work on Nerve Pain

Several biological mechanisms have been proposed for why sticking needles into specific facial and body points could dampen trigeminal pain. The most well-studied pathway involves the body’s own opioid system. Acupuncture appears to raise levels of beta-endorphin, a natural painkiller, while reducing substance P, a molecule that amplifies pain signaling. In trigeminal neuralgia patients specifically, studies have found that pain improvements after acupuncture track with these changes in blood chemistry.⁹

A second proposed mechanism involves inflammatory molecules. Tumor necrosis factor-alpha and interleukin-6 can ramp up the excitability of nerve cells by interacting with ion channels on their surfaces. Acupuncture has been shown to reduce levels of these inflammatory signals in trigeminal neuralgia patients, and those reductions correlate with better pain scores and improved quality of life.⁹ A third line of research suggests that electroacupuncture can suppress certain pain-sensing receptors (particularly TRPV1 channels) in nerve cells, effectively turning down the volume on pain signals at the cellular level.

Work in animal models of related conditions supports the idea that electroacupuncture dampens central sensitization, the process by which the nervous system turns up its pain amplifier after repeated stimulation. In a rat model of migraine (which shares some neurobiology with trigeminal neuralgia), electroacupuncture reduced the activation of immune cells in the brainstem and limited inflammatory signaling pathways there.¹⁰ Beyond peripheral and spinal effects, there is evidence that acupuncture helps remodel abnormal brain connectivity in pain-processing regions like the anterior cingulate cortex and insula, areas known to be involved in the emotional and sensory dimensions of chronic pain.¹¹

None of these mechanisms are unique to trigeminal neuralgia; they overlap with what has been observed in acupuncture research on other chronic pain conditions. That overlap actually makes the story more plausible rather than less, because the same endorphin and anti-inflammatory pathways are relevant across many types of nerve pain.

Different Acupuncture Approaches and Which Might Work Best

Not all acupuncture for trigeminal neuralgia looks the same. The most commonly studied approach is manual acupuncture, where thin needles are inserted and gently manipulated by hand. Electroacupuncture adds mild electrical current through the needles, which produces more consistent and measurable stimulation. Other techniques include bloodletting therapy (pricking specific points to draw a small amount of blood) and combining acupuncture with conventional medication.

A network meta-analysis attempted to compare these different approaches head to head. It found that bloodletting therapy ranked highest for overall treatment effectiveness and pain score reduction, while acupuncture combined with standard Western medicine performed best for reducing attack frequency and lowering side effects.¹² The certainty of most of these comparisons ranged from low to very low, though, so these rankings should be treated as preliminary signals rather than definitive guidance.

The 2024 factorial trial specifically used electroacupuncture and found that combining it with carbamazepine produced substantially larger pain reductions than either treatment alone.⁶ The practical takeaway for now is that acupuncture probably works best as an add-on to medication rather than a complete replacement, at least based on the strongest available evidence.

Safety and Side Effects

Across the studies reviewed, acupuncture’s side-effect profile is consistently mild. The most commonly reported problems are minor bruising, temporary soreness at needle sites, and occasional light-headedness during sessions. Systematic reviews have found that adverse effects from acupuncture were mild in the few studies that reported them.⁸

The comparison to standard treatments is striking. One analysis estimated side-effect rates of about 23 percent for acupuncture, compared to roughly 25 percent for surgery and nearly 89 percent for drug therapy.¹³ The 2023 meta-analysis similarly found that acupuncture was associated with fewer adverse events than carbamazepine.⁴ Even if the pain benefits of acupuncture turn out to be smaller than current studies suggest, the favorable safety profile means the risk of trying it is low, especially for patients who cannot tolerate medication side effects.

That said, trigeminal neuralgia involves the face, and needling near inflamed or hypersensitive nerves could theoretically trigger an attack during treatment. Patients should work with a practitioner experienced in treating facial pain conditions, and communication about trigger zones is important before any session.

What It Costs Compared to Other Options

Cost is rarely discussed in clinical trials, but one analysis projected long-term expenses for the three main treatment paths. Over five years, acupuncture was estimated at about £750 (roughly $950 USD), compared to roughly £1,500 for carbamazepine and nearly £4,900 for microvascular decompression surgery.¹³ These are estimates from a single modeling study and will vary enormously depending on local healthcare costs, insurance coverage, and how many sessions a patient needs. But the relative ranking is probably right in broad strokes: acupuncture is less expensive than long-term medication, which is less expensive than surgery.

Insurance coverage for acupuncture varies widely. Some plans in the United States now cover acupuncture for chronic pain conditions following broader acceptance of the treatment for low back pain, but coverage specifically for trigeminal neuralgia is far less consistent. Patients should check with their insurer before assuming costs will be reimbursed.

Where Needles Meet Nerves

One interesting piece of the puzzle is the anatomical relationship between traditional acupuncture points on the face and the trigeminal nerve itself. The trigeminal nerve splits into three main branches that supply sensation to the forehead, cheek, and jaw, and these branches emerge through specific bony openings in the skull before fanning out across the face. Research mapping facial acupuncture points against the trigeminal nerve’s anatomy found that the points traditionally used for facial pain sit directly over areas where the nerve branches emerge, bifurcate, or form connections with other nerves.¹⁴ Areas of high nerve density corresponded to clusters of acupuncture points.

This alignment was not designed by modern neuroscientists; it emerged from centuries of empirical practice in traditional Chinese medicine. Whether that represents genuine clinical insight refined over time or a coincidence of anatomy is debatable, but the overlap is striking enough that it provides a plausible anatomical basis for why facial acupuncture points might influence trigeminal nerve signaling. The researchers classified facial acupuncture targets into four categories based on how they relate to the nerve: trunk points (near the main nerve), bifurcation points (where the nerve splits), branch points (along smaller divisions), and anastomosis points (where nerve branches connect). This kind of mapping could eventually help standardize which points practitioners target for trigeminal neuralgia specifically, rather than relying solely on traditional point prescriptions.

When Acupuncture Might Make Sense as Part of Your Plan

The current evidence suggests a few practical scenarios where acupuncture is a reasonable option. If you are taking carbamazepine or oxcarbazepine and getting partial relief but struggling with side effects, adding acupuncture sessions may let you reduce your medication dose while maintaining or improving pain control. The factorial trial’s finding that the combination outperformed either treatment alone supports this approach.⁶ If you cannot tolerate anticonvulsants at all, acupuncture alone showed real benefit over sham treatment in that same trial, making it a potential standalone option rather than merely a complement.

If you are considering or recovering from surgery, the evidence is thinner. No well-designed trials have specifically tested acupuncture as a post-surgical treatment for residual or recurrent trigeminal pain. Given that about 30 percent of surgical patients experience pain recurrence,³ this is a gap worth filling with future research.

Acupuncture is not a cure for trigeminal neuralgia. No study has shown it permanently resolves the condition, and the underlying cause, often a blood vessel compressing the nerve, is not something needles can fix structurally. What the evidence does support is that acupuncture can meaningfully reduce the frequency and severity of pain attacks with minimal risk, particularly when used alongside conventional treatment. For a condition this painful and this frustrating to manage, that is a contribution worth taking seriously even while waiting for better studies to sharpen the picture.

Acupuncture and the Search for Relief in Chronic Facial Pain

Trigeminal neuralgia does not exist in a vacuum. Many patients dealing with chronic orofacial pain explore multiple treatment avenues simultaneously, including acupuncture, massage, and movement-based therapies.¹⁵ This pattern of seeking diverse treatments reflects both the severity of chronic facial pain and the reality that no single approach works perfectly for everyone. Qualitative research on patients with chronic orofacial conditions reveals a common journey: initial reliance on conventional medicine, dissatisfaction with side effects or incomplete relief, and then a gradual expansion into complementary treatments.

For acupuncture specifically, the treatment experience itself may matter beyond the measurable pain outcomes. Sessions are typically 20 to 40 minutes, involve little to no discomfort compared to the attacks themselves, and give patients a sense of active participation in their care. In a condition that often leaves people feeling helpless between medication adjustments and surgical consultations, that participatory element has real psychological value. None of that replaces the need for hard efficacy data, but it helps explain why patients with trigeminal neuralgia consistently rate acupuncture as a treatment worth continuing even when their neurologists remain cautious about endorsing it.